Eperzan albiglutide regulatory update

GlaxoSmithKline said FDA extended the PDUFA date by 3 months for a BLA for albiglutide to treat Type II diabetes. The new date is April 15, 2014; it was Jan. 15, 2014. According to GSK, the agency nee...